{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:19:25Z","timestamp":1787649565294,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-10617-7","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T11:02:16Z","timestamp":1707476536000},"page":"5529-5540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Eloi","family":"Varin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Beunon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gis\u00e8le","family":"N\u2019Kontchou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo-Carlo","family":"Pescatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Ganne-Carri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-9652","authenticated-orcid":false,"given":"Olivier","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"10617_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2017.10.004","volume":"68","author":"JC Nault","year":"2018","unstructured":"Nault JC, Sutter O, Nahon P, Ganne-Carrie N, Seror O (2018) Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations. J Hepatol 68:783\u2013797","journal-title":"J Hepatol"},{"key":"10617_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/02656736.2021.1941311","volume":"39","author":"T De Baere","year":"2022","unstructured":"De Baere T, Tselikas L, Delpla A et al (2022) Thermal ablation in the management of oligometastatic colorectal cancer. Int J Hyperthermia 39:627\u2013632","journal-title":"Int J Hyperthermia"},{"key":"10617_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.diii.2015.04.007","volume":"96","author":"O Seror","year":"2015","unstructured":"Seror O (2015) Ablative therapies: advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient? Diagn Interv Imaging 96:617\u2013624","journal-title":"Diagn Interv Imaging"},{"key":"10617_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J et al (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 76:681\u2013693","journal-title":"J Hepatol"},{"key":"10617_CR5","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s00330-018-5902-4","volume":"29","author":"J Uhlig","year":"2019","unstructured":"Uhlig J, Sellers CM, Stein SM, Kim HS (2019) Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database. Eur Radiol 29:2679\u20132689","journal-title":"Eur Radiol"},{"key":"10617_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jhep.2013.04.009","volume":"59","author":"A Cucchetti","year":"2013","unstructured":"Cucchetti A, Piscaglia F, Cescon M et al (2013) Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol 59:300\u2013307","journal-title":"J Hepatol"},{"key":"10617_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000502744","volume":"9","author":"M Maeda","year":"2020","unstructured":"Maeda M, Saeki I, Sakaida I et al (2020) Complications after radiofrequency ablation for hepatocellular carcinoma: a multicenter study involving 9,411 Japanese patients. Liver Cancer 9:50\u201362","journal-title":"Liver Cancer"},{"key":"10617_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000111710","volume":"72","author":"H Kasugai","year":"2007","unstructured":"Kasugai H, Osaki Y, Oka H, Kudo M, Seki T (2007) Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Oncology 72:72\u201375","journal-title":"Oncology"},{"key":"10617_CR9","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1007\/s00330-020-07409-0","volume":"31","author":"P Schullian","year":"2021","unstructured":"Schullian P, Johnston E, Laimer G et al (2021) Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience. Eur Radiol 31:3042\u20133052","journal-title":"Eur Radiol"},{"key":"10617_CR10","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1872-034X.2012.01025.x","volume":"42","author":"M Koda","year":"2012","unstructured":"Koda M, Murawaki Y, Hirooka Y et al (2012) Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: an analysis of 16 346 treated nodules in 13 283 patients. Hepatol Res 42:1058\u20131064","journal-title":"Hepatol Res"},{"key":"10617_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s10620-016-4312-1","volume":"62","author":"MX Lin","year":"2017","unstructured":"Lin MX, Ye JY, Tian WS et al (2017) Risk factors for bile duct injury after percutaneous thermal ablation of malignant liver tumors: a retrospective case-control study. Dig Dis Sci 62:1086\u20131094","journal-title":"Dig Dis Sci"},{"key":"10617_CR12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00270-020-02471-z","volume":"43","author":"L Crocetti","year":"2020","unstructured":"Crocetti L, de Baere T, Pereira PL, Tarantino FP (2020) CIRSE Standards of Practice on Thermal Ablation of Liver Tumours. Cardiovasc Intervent Radiol 43:951\u2013962","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10617_CR13","doi-asserted-by":"crossref","unstructured":"Kim SH, Lim HK, Choi D et al (2004) Changes in bile ducts after radiofrequency ablation of hepatocellular carcinoma: frequency and clinical significance. AJR Am J Roentgenol 183:1611\u20131617","DOI":"10.2214\/ajr.183.6.01831611"},{"key":"10617_CR14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2214\/AJR.09.3946","volume":"195","author":"IS Chang","year":"2010","unstructured":"Chang IS, Rhim H, Kim SH et al (2010) Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance. AJR Am J Roentgenol 195:1131\u20131136","journal-title":"AJR Am J Roentgenol"},{"key":"10617_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1478-3231.2010.02415.x","volume":"31","author":"Y Kondo","year":"2011","unstructured":"Kondo Y, Shiina S, Tateishi R et al (2011) Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient\u2019s prognosis. Liver Int 31:197\u2013205","journal-title":"Liver Int"},{"key":"10617_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3348\/kjr.2023.0423","volume":"24","author":"S Han","year":"2023","unstructured":"Han S, Lee MW, Lee YJ, Hong HP, Lee DH, Lee JM (2023) No-touch radiofrequency ablation for early hepatocellular carcinoma: 2023 Korean Society of Image-Guided Tumor Ablation Guidelines. Korean J Radiol 24:719\u2013728","journal-title":"Korean J Radiol"},{"key":"10617_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1148\/radiol.2016150743","volume":"280","author":"O Seror","year":"2016","unstructured":"Seror O, N\u2019Kontchou G, Nault J-C et al (2016) Hepatocellular carcinoma within milan criteria: no-touch multibipolar radiofrequency ablation for treatment\u2014long-term results. Radiology 280:611\u2013621","journal-title":"Radiology"},{"key":"10617_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.21037\/hbsn-21-512","volume":"11","author":"O Seror","year":"2022","unstructured":"Seror O (2022) No touch radiofrequency ablation for hepatocellular carcinoma: a conceptual approach rather than an iron law. Hepatobiliary Surg Nutr 11:132\u2013135","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10617_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jhep.2016.07.010","volume":"66","author":"A Hocquelet","year":"2017","unstructured":"Hocquelet A, Aube C, Rode A et al (2017) Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC. J Hepatol 66:67\u201374","journal-title":"J Hepatol"},{"key":"10617_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jvir.2013.11.025","volume":"25","author":"O Seror","year":"2014","unstructured":"Seror O, N\u2019Kontchou G, Van Nhieu JT et al (2014) Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteria. J Vasc Interv Radiol 25:599\u2013607","journal-title":"J Vasc Interv Radiol"},{"key":"10617_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00330-022-08991-1","volume":"33","author":"TH Kim","year":"2023","unstructured":"Kim TH, Lee JM, Lee DH, Joo I, Park SJ, Yoon JH (2023) Can \u201cno-touch\u201d radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis. Eur Radiol 33:545\u2013554","journal-title":"Eur Radiol"},{"key":"10617_CR22","unstructured":"European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 69:182\u2013236.\u00a0https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0168827818302150"},{"key":"10617_CR23","doi-asserted-by":"publisher","first-page":"15375","DOI":"10.1038\/s41598-017-15491-6","volume":"7","author":"H Hu","year":"2017","unstructured":"Hu H, Zheng Q, Huang Y et al (2017) A non-smooth tumor margin on preoperative imaging assesses microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis. Sci Rep 7:15375","journal-title":"Sci Rep"},{"key":"10617_CR24","doi-asserted-by":"publisher","first-page":"110010","DOI":"10.1016\/j.ejrad.2021.110010","volume":"147","author":"M Renzulli","year":"2022","unstructured":"Renzulli M, Dajti E, Ierardi AM et al (2022) Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients. Eur J Radiol 147:110010","journal-title":"Eur J Radiol"},{"key":"10617_CR25","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1053\/j.gastro.2018.03.035","volume":"154","author":"M Guillaume","year":"2018","unstructured":"Guillaume M, Bureau C (2018) Should the presence of spontaneous portosystemic shunts be implemented to the model for end-stage liver disease score for a better prediction of outcome? Gastroenterology 154:1569\u20131571","journal-title":"Gastroenterology"},{"key":"10617_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria\u2014a 10-year update. Radiology 273:241\u2013260","journal-title":"Radiology"},{"key":"10617_CR27","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","volume":"14","author":"D Sacks","year":"2003","unstructured":"Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199-202","journal-title":"J Vasc Interv Radiol"},{"key":"10617_CR28","doi-asserted-by":"publisher","first-page":"20201327","DOI":"10.1259\/bjr.20201327","volume":"94","author":"G Brehier","year":"2021","unstructured":"Brehier G, Besnier L, Delagnes A et al (2021) Imaging after percutaneous thermal and non-thermal ablation of hepatic tumour: normal appearances, progression and complications. Br J Radiol 94:20201327","journal-title":"Br J Radiol"},{"key":"10617_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12350-019-01624-z","volume":"26","author":"CJ Morgan","year":"2019","unstructured":"Morgan CJ (2019) Landmark analysis: A primer. J Nucl Cardiol 26:391\u2013393","journal-title":"J Nucl Cardiol"},{"key":"10617_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000076648","volume":"36","author":"F Marchal","year":"2004","unstructured":"Marchal F, Elias D, Rauch P et al (2004) Biliary lesions during radiofrequency ablation in liver. Study on the pig. Eur Surg Res 36:88\u201394","journal-title":"Eur Surg Res"},{"key":"10617_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1148\/radiol.12120486","volume":"267","author":"GD Dodd III","year":"2013","unstructured":"Dodd GD III, Dodd NA, Lanctot AC, Glueck DA (2013) Effect of variation of portal venous blood flow on radiofrequency and microwave ablations in a blood-perfused bovine liver model. Radiology 267:129\u2013136","journal-title":"Radiology"},{"key":"10617_CR32","doi-asserted-by":"publisher","first-page":"18712","DOI":"10.1038\/s41598-022-23315-5","volume":"12","author":"E Gigante","year":"2022","unstructured":"Gigante E, Haddad Y, Nault JC et al (2022) Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation. Sci Rep 12:18712","journal-title":"Sci Rep"},{"key":"10617_CR33","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/s00330-022-09105-7","volume":"33","author":"H Cha","year":"2023","unstructured":"Cha H, Choi JY, Park YN et al (2023) Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI. Eur Radiol 33:1364\u20131377","journal-title":"Eur Radiol"},{"key":"10617_CR34","doi-asserted-by":"crossref","unstructured":"Yamashita Y-i, Yamamoto H, Miyata H et al (2021) Risk factors for bile leakage: Latest analysis of 10 102 hepatectomies for hepatocellular carcinoma from the Japanese national clinical database. J Hepatobiliary Pancreat Sci 28:556\u2013562","DOI":"10.1002\/jhbp.827"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-10617-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-10617-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-10617-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:08:11Z","timestamp":1725019691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-10617-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["10617"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-10617-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"assertion":[{"value":"7 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Olivier Sutter.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (JCN) has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained (CLEA-2023-n\u00b0346)","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 retrospective\u2022 observational\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}